Japan's MHLW Calls Attention To Liver Failure Associated With Tamiflu
This article was originally published in PharmAsia News
Executive Summary
Japan's Ministry of Health, Labor and Welfare reported cases of fulminate hepatic failure associated with flu drug Tamiflu. According to Chugai Pharmaceuticals, Tamiflu's importer and distributor in Japan, two deaths from fulminate hepatic failure after taking Tamiflu were reported since the market launch of the drug in 2001. MHLW also requested a warning label change to Tamiflu. (Click here for more - Japanese language) "MHLW Calls Attentions To Fulminate Hepatic Failure Caused By Taking Tamiflu" - Yomiuri News (3/1/08)